BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 34687392)

  • 1. Comprehensive overview of extracellular vesicle proteomics in meningioma: future strategy.
    Rana R; Sharma S; Ganguly NK
    Mol Biol Rep; 2021 Dec; 48(12):8061-8074. PubMed ID: 34687392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis discovers the differential expression of novel proteins and phosphoproteins in meningioma including NEK9, HK2 and SET and deregulation of RNA metabolism.
    Dunn J; Ferluga S; Sharma V; Futschik M; Hilton DA; Adams CL; Lasonder E; Hanemann CO
    EBioMedicine; 2019 Feb; 40():77-91. PubMed ID: 30594554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiality of Exosomal Proteins as Novel Cancer Biomarkers for Liquid Biopsy.
    Hu C; Jiang W; Lv M; Fan S; Lu Y; Wu Q; Pi J
    Front Immunol; 2022; 13():792046. PubMed ID: 35757760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma.
    Negroni C; Hilton DA; Ercolano E; Adams CL; Kurian KM; Baiz D; Hanemann CO
    EBioMedicine; 2020 Sep; 59():102941. PubMed ID: 32810829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas.
    Sofela AA; Hilton DA; Ammoun S; Baiz D; Adams CL; Ercolano E; Jenkinson MD; Kurian KM; Teo M; Whitfield PC; Sahm F; Hanemann CO
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33429944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large Extracellular Vesicles-A New Frontier of Liquid Biopsy in Oncology.
    Pezzicoli G; Tucci M; Lovero D; Silvestris F; Porta C; Mannavola F
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32906787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies.
    Li D; Lai W; Fan D; Fang Q
    Am J Physiol Cell Physiol; 2021 Nov; 321(5):C779-C797. PubMed ID: 34495763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Plasma Extracellular Vesicle Isolation and Proteomic Characterization for the Optimization of Liquid Biopsy in Multiple Myeloma.
    Reale A; Khong T; Xu R; Chen M; Mithraprabhu S; Bingham N; Spencer A; Greening DW
    Methods Mol Biol; 2021; 2261():151-191. PubMed ID: 33420989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal proteins as potential markers of tumor diagnosis.
    Li A; Zhang T; Zheng M; Liu Y; Chen Z
    J Hematol Oncol; 2017 Dec; 10(1):175. PubMed ID: 29282096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-497 and 219 in blood aid meningioma classification.
    Abdelrahman A; Negroni C; Sahm F; Adams CL; Urbanic-Purkart T; Khalil M; Vergura R; Morelli C; Hanemann CO
    J Neurooncol; 2022 Oct; 160(1):137-147. PubMed ID: 36076132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
    Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
    Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic potential of extracellular vesicles in meningioma patients.
    Ricklefs FL; Maire CL; Wollmann K; Dührsen L; Fita KD; Sahm F; Herold-Mende C; von Deimling A; Kolbe K; Holz M; Bergmann L; Fuh MM; Schlüter H; Alawi M; Reimer R; Peine S; Glatzel M; Westphal M; Lamszus K
    Neuro Oncol; 2022 Dec; 24(12):2078-2090. PubMed ID: 35551407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
    Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
    Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
    Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
    Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging clinical potential of circulating extracellular vesicles for non-invasive glioma diagnosis and disease monitoring.
    Hallal S; Ebrahimkhani S; Shivalingam B; Graeber MB; Kaufman KL; Buckland ME
    Brain Tumor Pathol; 2019 Apr; 36(2):29-39. PubMed ID: 30859343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer.
    Torrano V; Royo F; Peinado H; Loizaga-Iriarte A; Unda M; Falcón-Perez JM; Carracedo A
    Curr Opin Pharmacol; 2016 Aug; 29():47-53. PubMed ID: 27366992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade.
    Schmidt M; Mock A; Jungk C; Sahm F; Ull AT; Warta R; Lamszus K; Gousias K; Ketter R; Roesch S; Rapp C; Schefzyk S; Urbschat S; Lahrmann B; Kessler AF; Löhr M; Senft C; Grabe N; Reuss D; Beckhove P; Westphal M; von Deimling A; Unterberg A; Simon M; Herold-Mende C
    Oncotarget; 2016 Mar; 7(12):14551-68. PubMed ID: 26894859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent Advances in Exosomal Protein Detection Via Liquid Biopsy Biosensors for Cancer Screening, Diagnosis, and Prognosis.
    Liu C; Yang Y; Wu Y
    AAPS J; 2018 Mar; 20(2):41. PubMed ID: 29520676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplatform profiling of meningioma provides molecular insight and prioritization of drug targets for rational clinical trial design.
    Everson RG; Hashimoto Y; Freeman JL; Hodges TR; Huse J; Zhou S; Xiu J; Spetzler D; Sanai N; Kim L; Kesari S; Brenner A; De Monte F; Heimberger A; Raza SM
    J Neurooncol; 2018 Sep; 139(2):469-478. PubMed ID: 29846894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicles as source for the identification of minimally invasive molecular signatures in glioblastoma.
    Rackles E; Lopez PH; Falcon-Perez JM
    Semin Cancer Biol; 2022 Dec; 87():148-159. PubMed ID: 36375777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.